TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP June 20, 2014
TCL Archive Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center March 5, 1999
